Molecular determinants of HIV-1 subtype C coreceptor transition from R5 to R5X4

Virology

Volumn 407, Issue 1, 2010, Pages 68-79

  Zhang, Hong ^a,b   Tully, Damien C ^a,b   Zhang, Tiejun ^a,b   Moriyama, Hideaki ^b   Thompson, Jesse ^a,b   Wood, Charles ^a,b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA   (United States)

Author keywords

Coreceptor switch; Envelope glycoproteins; HIV 1 subtype C

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENE INSERTION; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MODIFICATION; VIRUS ENVELOPE; VIRUS TYPING; CHEMICAL STRUCTURE; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFANT; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PRESCHOOL CHILD; PROTEIN TERTIARY STRUCTURE; VIRAL TROPISM; VIRUS ATTACHMENT;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CHILD, PRESCHOOL; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HUMANS; INFANT; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, HIV; SEQUENCE ANALYSIS, DNA; VIRAL TROPISM; VIRUS ATTACHMENT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77956921525     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.07.047     Document Type: Article

References (80)

1. Abebe A., Demissie D., Goudsmit J., Brouwer M., Kuiken C.L., Pollakis G., Schuitemaker H., Fontanet A.L., Rinke de Wit T.F. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS 1999, 13(11):1305-1311.
2. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272(5270):1955-1958.
3. Arnold K., Bordoli L., Kopp J., Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006, 22(2):195-201.
4. Basmaciogullari S., Babcock G.J., Van Ryk D., Wojtowicz W., Sodroski J. Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding. J. Virol. 2002, 76(21):10791-10800.
5. Berger E.A., Doms R.W., Fenyo E.M., Korber B.T., Littman D.R., Moore J.P., Sattentau Q.J., Schuitemaker H., Sodroski J., Weiss R.A. A new classification for HIV-1. Nature 1998, 391(6664):240.
6. Bjorndal A., Deng H., Jansson M., Fiore J.R., Colognesi C., Karlsson A., Albert J., Scarlatti G., Littman D.R., Fenyo E.M. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 1997, 71(10):7478-7487.
7. Bjorndal A., Sonnerborg A., Tscherning C., Albert J., Fenyo E.M. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res. Hum. Retroviruses 1999, 15(7):647-653.
8. Brelot A., Heveker N., Adema K., Hosie M.J., Willett B., Alizon M. Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses. J. Virol. 1999, 73(4):2576-2586.
9. Cardozo T., Kimura T., Philpott S., Weiser B., Burger H., Zolla-Pazner S. Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res. Hum. Retroviruses 2007, 23(3):415-426.
10. Carrillo A., Ratner L. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants. J. Virol. 1996, 70(2):1301-1309.
11. Cecilia D., Kulkarni S.S., Tripathy S.P., Gangakhedkar R.R., Paranjape R.S., Gadkari D.A. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 2000, 271(2):253-258.
12. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85(7):1135-1148.
13. Choge I., Cilliers T., Walker P., Taylor N., Phoswa M., Meyers T., Viljoen J., Violari A., Gray G., Moore P.L., Papathanosopoulos M., Morris L. Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression. AIDS Res. Hum. Retroviruses 2006, 22(5):458-465.
14. Cilliers T., Nhlapo J., Coetzer M., Orlovic D., Ketas T., Olson W.C., Moore J.P., Trkola A., Morris L. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J. Virol. 2003, 77(7):4449-4456.
15. Cocchi F., DeVico A.L., Garzino-Demo A., Cara A., Gallo R.C., Lusso P. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 1996, 2(11):1244-1247.
16. Coetzer M., Cilliers T., Ping L.H., Swanstrom R., Morris L. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates. Virology 2006, 356(1-2):95-105.
17. Connell B.J., Michler K., Capovilla A., Venter W.D., Stevens W.S., Papathanasopoulos M.A. Emergence of X4 usage among HIV-1 subtype C: evidence for an evolving epidemic in South Africa. AIDS 2008, 22(7):896-899.
18. Connor R.I., Sheridan K.E., Ceradini D., Choe S., Landau N.R. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 1997, 185(4):621-628.
19. Cormier E.G., Dragic T. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J. Virol. 2002, 76(17):8953-8957.
20. De Jong J.J., De Ronde A., Keulen W., Tersmette M., Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 1992, 66(11):6777-6780.
21. DeLano W.L. The PyMOL Molecular Graphics System 2008, DeLano Scientific LLC, Palo Alto, CA, USA, http://www.pymol.org.
22. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381(6584):661-666.
23. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S.C., Parmentier M., Collman R.G., Doms R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996, 85(7):1149-1158.
24. Doranz B.J., Orsini M.J., Turner J.D., Hoffman T.L., Berson J.F., Hoxie J.A., Peiper S.C., Brass L.F., Doms R.W. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions. J. Virol. 1999, 73(4):2752-2761.
25. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381(6584):667-673.
26. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272(5263):872-877.
27. Fouchier R.A., Groenink M., Kootstra N.A., Tersmette M., Huisman H.G., Miedema F., Schuitemaker H. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 1992, 66(5):3183-3187.
28. Hartley O., Klasse P.J., Sattentau Q.J., Moore J.P. V3: HIV's switch-hitter. AIDS Res. Hum. Retroviruses 2005, 21(2):171-189.
29. Hoffman T.L., Doms R.W. HIV-1 envelope determinants for cell tropism and chemokine receptor use. Mol. Membr. Biol. 1999, 16(1):57-65.
30. Hoffman N.G., Seillier-Moiseiwitsch F., Ahn J., Walker J.M., Swanstrom R. Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J. Virol. 2002, 76(8):3852-3864.
31. Huang C.C., Tang M., Zhang M.Y., Majeed S., Montabana E., Stanfield R.L., Dimitrov D.S., Korber B., Sodroski J., Wilson I.A., Wyatt R., Kwong P.D. Structure of a V3-containing HIV-1 gp120 core. Science 2005, 310(5750):1025-1028.
32. Huang C.C., Lam S.N., Acharya P., Tang M., Xiang S.H., Hussan S.S., Stanfield R.L., Robinson J., Sodroski J., Wilson I.A., Wyatt R., Bewley C.A., Kwong P.D. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 2007, 317(5846):1930-1934.
33. Huang W., Toma J., Fransen S., Stawiski E., Reeves J.D., Whitcomb J.M., Parkin N., Petropoulos C.J. Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein. J. Virol. 2008, 82(11):5584-5593.
34. Hung C.S., Vander Heyden N., Ratner L. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization. J. Virol. 1999, 73(10):8216-8226.
35. Hwang S.S., Boyle T.J., Lyerly H.K., Cullen B.R. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991, 253(5015):71-74.
36. Im W., Beglov D., Roux B. Continuum solvation model: computation of electrostatic forces from numerical solutions to the Poisson-Boltzmann equation. Comput. Phys. Commun. 1998, 111:59-75.
37. Jensen M.A., Li F.S., van 't Wout A.B., Nickle D.C., Shriner D., He H.X., McLaughlin S., Shankarappa R., Margolick J.B., Mullins J.I. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J. Virol. 2003, 77(24):13376-13388.
38. Jensen M.A., Coetzer M., van 't Wout A.B., Morris L., Mullins J.I. A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J. Virol. 2006, 80(10):4698-4704.
39. Jo S., Vargyas M., Vasko-Szedlar J., Roux B., Im W. PBEQ-Solver for online visualization of electrostatic potential of biomolecules. Nucleic Acids Res. 2008, 36:W270-W275. (Web Server issue).
40. Johnston E.R., Zijenah L.S., Mutetwa S., Kantor R., Kittinunvorakoon C., Katzenstein D.A. High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. J. Virol. 2003, 77(13):7682-7688.
41. Kajumo F., Thompson D.A., Guo Y., Dragic T. Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4. Virology 2000, 271(2):240-247.
42. Karlsson A., Parsmyr K., Sandstrom E., Fenyo E.M., Albert J. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 1994, 32(2):364-370.
43. Kassaye S., Johnston E., McColgan B., Kantor R., Zijenah L., Katzenstein D. Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2009, 50(1):9-18.
44. Labrosse B., Treboute C., Brelot A., Alizon M. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor. J. Virol. 2001, 75(12):5457-5464.
45. Maas J.J., Gange S.J., Schuitemaker H., Coutinho R.A., van Leeuwen R., Margolick J.B. Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study. AIDS 2000, 14(9):1155-1161.
46. Maeda Y., Yusa K., Harada S. Altered sensitivity of an R5X4 HIV-1 strain 89.6 to coreceptor inhibitors by a single amino acid substitution in the V3 region of gp120. Antiviral Res. 2008, 77(2):128-135.
47. McCormack G.P., Glynn J.R., Crampin A.C., Sibande F., Mulawa D., Bliss L., Broadbent P., Abarca K., Ponnighaus J.M., Fine P.E., Clewley J.P. Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi. J. Virol. 2002, 76(24):12890-12899.
48. Michael N.L., Chang G., Louie L.G., Mascola J.R., Dondero D., Birx D.L., Sheppard H.W. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat. Med. 1997, 3(3):338-340.
49. Michler K., Connell B.J., Venter W.D., Stevens W.S., Capovilla A., Papathanasopoulos M.A. Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4. AIDS Res. Hum. Retroviruses 2008, 24(5):743-751.
50. Milich L., Margolin B.H., Swanstrom R. Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein. Virology 1997, 239(1):108-118.
51. Miller E.D., Duus K.M., Townsend M., Yi Y., Collman R., Reitz M., Su L. Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism. J. Virol. 2001, 75(18):8498-8506.
52. Morris L., Cilliers T., Bredell H., Phoswa M., Martin D.J. CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis. AIDS Res. Hum. Retroviruses 2001, 17(8):697-701.
53. Mosier D.E. How HIV changes its tropism: evolution and adaptation?. Curr. Opin. HIV AIDS 2009, 4(2):125-130.
54. Nabatov A.A., Pollakis G., Linnemann T., Kliphius A., Chalaby M.I., Paxton W.A. Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies. J. Virol. 2004, 78(1):524-530.
55. Ndung'u T., Sepako E., McLane M.F., Chand F., Bedi K., Gaseitsiwe S., Doualla-Bell F., Peter T., Thior I., Moyo S.M., Gilbert P.B., Novitsky V.A., Essex M. HIV-1 subtype C in vitro growth and coreceptor utilization. Virology 2006, 347(2):247-260.
56. Nolan K.M., Jordan A.P., Hoxie J.A. Effects of partial deletions within the human immunodeficiency virus type 1 V3 loop on coreceptor tropism and sensitivity to entry inhibitors. J. Virol. 2008, 82(2):664-673.
57. Ogert R.A., Lee M.K., Ross W., Buckler-White A., Martin M.A., Cho M.W. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J. Virol. 2001, 75(13):5998-6006.
58. Papathanasopoulos M.A., Hunt G.M., Tiemessen C.T. Evolution and diversity of HIV-1 in Africa-a review. Virus Genes 2003, 26(2):151-163.
59. Pastore C., Nedellec R., Ramos A., Pontow S., Ratner L., Mosier D.E. Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations. J. Virol. 2006, 80(2):750-758.
60. Patel M.B., Hoffman N.G., Swanstrom R. Subtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins. J. Virol. 2008, 82(2):903-916.
61. Ping L.H., Nelson J.A., Hoffman I.F., Schock J., Lamers S.L., Goodman M., Vernazza P., Kazembe P., Maida M., Zimba D., Goodenow M.M., Eron J.J., Fiscus S.A., Cohen M.S., Swanstrom R. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J. Virol. 1999, 73(8):6271-6281.
62. Pollakis G., Kang S., Kliphuis A., Chalaby M.I., Goudsmit J., Paxton W.A. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J. Biol. Chem. 2001, 276(16):13433-13441.
63. Pollakis G., Abebe A., Kliphuis A., Chalaby M.I.M., Bakker M., Mengistu Y., Brouwer M., Goudsmit J., Schuitemaker H., Paxton W.A. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals. J. Virol. 2004, 78(6):2841-2852.
64. Pond S.L., Frost S.D. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 2005, 21(10):2531-2533.
65. Pond S.L., Frost S.D., Muse S.V. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21(5):676-679.
66. Rana S., Besson G., Cook D.G., Rucker J., Smyth R.J., Yi Y., Turner J.D., Guo H.H., Du J.G., Peiper S.C., Lavi E., Samson M., Libert F., Liesnard C., Vassart G., Doms R.W., Parmentier M., Collman R.G. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation. J. Virol. 1997, 71(4):3219-3227.
67. Raymond S., Delobel P., Mavigner M., Ferradini L., Cazabat M., Souyris C., Sandres-Saune K., Pasquier C., Marchou B., Massip P., Izopet J. Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses. J. Acquir. Immune Defic. Syndr. 2010, 53(2):167-175.
68. Reitz M.S., Hall L., Robert-Guroff M., Lautenberger J., Hahn B.M., Shaw G.M., Kong L.I., Weiss S.H., Waters D., Gallo R.C., et al. Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB). AIDS Res. Hum. Retroviruses 1994, 10(9):1143-1155.
69. Richman D.D., Bozzette S.A. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 1994, 169(5):968-974.
70. Rizzuto C.D., Wyatt R., Hernandez-Ramos N., Sun Y., Kwong P.D., Hendrickson W.A., Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998, 280(5371):1949-1953.
71. Scarlatti G., Tresoldi E., Bjorndal A., Fredriksson R., Colognesi C., Deng H.K., Malnati M.S., Plebani A., Siccardi A.G., Littman D.R., Fenyo E.M., Lusso P. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 1997, 3(11):1259-1265.
72. Schuitemaker H., Koot M., Kootstra N.A., Dercksen M.W., de Goede R.E., van Steenwijk R.P., Lange J.M., Schattenkerk J.K., Miedema F., Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 1992, 66(3):1354-1360.
73. Shioda T., Levy J.A., Cheng-Mayer C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 1991, 349(6305):167-169.
74. Shioda T., Oka S., Ida S., Nokihara K., Toriyoshi H., Mori S., Takebe Y., Kimura S., Shimada K., Nagai Y., et al. A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. J. Virol. 1994, 68(12):7689-7696.
75. Singh A., Page T., Moore P.L., Allgaier R.L., Hiramen K., Coovadia H.M., Walker B.D., Morris L., Ndung'u T. Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates. Virology 2009, 393(1):56-67.
76. Tsibris A.M., Sagar M., Gulick R.M., Su Z., Hughes M., Greaves W., Subramanian M., Flexner C., Giguel F., Leopold K.E., Coakley E., Kuritzkes D.R. In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject. J. Virol. 2008, 82(16):8210-8214.
77. Wang J., Babcock G.J., Choe H., Farzan M., Sodroski J., Gabuzda D. N-linked glycosylation in the CXCR4 N-terminus inhibits binding to HIV-1 envelope glycoproteins. Virology 2004, 324(1):140-150.
78. Westervelt P., Trowbridge D.B., Epstein L.G., Blumberg B.M., Li Y., Hahn B.H., Shaw G.M., Price R.W., Ratner L. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 1992, 66(4):2577-2582.
79. Zhang H., Hoffmann F., He J., He X., Kankasa C., West J.T., Mitchell C.D., Ruprecht R.M., Orti G., Wood C. Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease. Retrovirology 2006, 3:73.
80. Zhang H., Rola M., West J.T., Tully D.C., Kubis P., He J., Kankasa C., Wood C. Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission. Virology 2010, 400(2):164-174.